Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New cream promises relief for dry, cracked skin in just 28 days

NCT ID NCT07393191

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a cosmetic cream can improve skin hydration and barrier function in adults with dry, very dry, sensitive, and cracked skin. 35 participants applied the cream twice daily for one month. Researchers measured skin moisture and water loss at several visits to see if the product helped. The goal was to ease discomfort like dryness, flaking, tightness, and itching.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

35 people

The number who actually took part.

Started

Dec 2024

Finished

Apr 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy female and male subjects (without specific repartition) * Caucasian ethnicity * Aged between 18 and 65 years old * Subjects with dry (\<30 c.u.), very dry (\<25 c.u.), sensitive and cracked skin * Subjects must show all the listed skin discomforts (skin dryness, desquamation, skin tightness, and itching * Subjects aware of the study procedures and having signed an informed consent form * Subjects registered with National Health Service (NHS) * Subjects certifying the truthfulness of the personal data disclosed to the investigator * Subjects able to understand the language used in the investigation and to respect the instructions given by the investigator as well as able to respect the study constraints and specific requirements * The pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) should be stable for at least one month without any changes expected or planned during the study * Commitment not to change the daily routine or the lifestyle * Subject informed about the study procedures and having signed the privacy policy Exclusion Criteria: * Subjects who do not fit the inclusion criteria. * Subjects with acute or chronic diseases able to interfere with the outcome of the study or that are considered dangerous for the subject or incompatible with the study requirements * Subjects participating or planning to participate in other clinical trials * Subjects deprived of freedom by administrative or legal decision or under guardianship * Subjects not able to be contacted in case of emergency * Subjects admitted to a health or social facility * Subjects planning a hospitalization during the study * Subjects who participated in a similar study without respecting an adequate washout period (14 days) * Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications * Cosmetic treatment known to interfere with the tested product (e.g.: laser, peeling) * Subjects having a skin disease or condition liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements * Subjects intolerant or allergic to one or more ingredients of the cosmetic product * Subjects that have shown allergies or sensitivity to cosmetic products, drugs, patch or medical devices * Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cracked skin are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Complife Italia

    San Martino Siccomario, Milano, 27028, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.